PSA e medidas antropométricas em índios da Amazônia: avaliação da comunidade Parkatejê

PSA e medidas antropométricas em índios da Amazônia: avaliação da comunidade Parkatejê

OBJETIVO: O rastreamento com o PSA (antígeno prostático específico) para detecção precoce de câncer de próstata em uma comunidade nativa tem grande importância epidemiológica. Assim, realizou-se estudo com objetivo de verificar a ocorrência do câncer da próstata em uma tribo indígena da Amazônia e u...

Full description

Bibliographic Details
Main Authors:	Homero Oliveira de Arruda, J P B Vieira Filho, V Ortiz, M Srougi
Format:	Article
Language:	English
Published:	Universidade de São Paulo
Series:	Revista de Saúde Pública
Subjects:	prostatic neoplasms prostate-specific antigen body mass index indians, south american anthropometry risk factors obesity acculturation food habits prevalence
Online Access:	http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102003000500012&lng=en&tlng=en

Similar Items

PSA e medidas antropométricas em índios da Amazônia: avaliação da comunidade Parkatejê PSA and anthropometric measurements among Amazon Indians: an evaluation of the Parkatejê community
by: Homero Oliveira de Arruda, et al.
Published: (2003-10-01)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Predictive value of PSA velocity over early clinical and pathological parameters in patients with localized prostate cancer who undergo radical retropubic prostatectomy
by: Martinez Carlos A.L., et al.
Published: (2004-01-01)

PSA kinetics before 40 years of age
by: Cristiano Linck Pazeto, et al.

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Predictive value of [-2]propsa (p2psa) and its derivatives for the prostate cancer detection in the 2.0 to 10.0ng/mL PSA range
by: I. Vukovic, et al.

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
by: Marcos F. Dall'oglio, et al.
Published: (2005-06-01)

PSA e medidas antropométricas em índios da Amazônia: avaliação da comunidade Parkatejê
by: Arruda Homero Oliveira de, et al.
Published: (2003-01-01)

Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
by: Jaegeun Lee, et al.
Published: (2021-04-01)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1
by: Lincoln GL Tan, et al.
Published: (2017-01-01)

The relation of serum PSA and Gleason's grade in patients with prostacic carcinoma
by: Živković Slađana, et al.
Published: (2003-01-01)

Controversies in using urine samples for prostate cancer detection: PSA and PCA3 expression analysis
by: S. Fontenete, et al.
Published: (2011-12-01)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
by: Oktay Uçer, et al.
Published: (2015-10-01)

Metastatic bone lesions of men in combination with an increase in serum PSA from the point of view of diagnosing carcinomas of unknown primary localization
by: O. V. Poslavska, et al.
Published: (2019-05-01)

A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?
by: Fernando Antônio Glasner da Rocha Araújo, et al.

Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1
by: Cheng Wang, et al.
Published: (2021-01-01)

Changes observed in prostate biopsy practices in an inner city hospital with a high risk patient population following the 2012 USPSTF PSA screening recommendations
by: Andrew W. Tam, et al.

Decision Tree Analysis for Prostate Cancer Prediction in Patients with Serum PSA 10 ng/ml or Less
by: Pantic Damjan N, et al.
Published: (2020-03-01)

Association between PSA values and surveillance quality after prostate cancer surgery
by: Christina Hunter Chapman, et al.
Published: (2019-12-01)

Evaluation of mucin histochemistry in benign and malignant prostatic lesion and their correlationPSA level
by: S Bastola, et al.
Published: (2014-11-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

DIAGNOSIS OF PROSTATIC NEOPLASM LATER TO ANTIBIOTIC TREATMENT IN PATIENTS WITH PROSTATE-SPECIFIC ANTIGEN BETWEEN 4 AND 10 ng/ml (IN SPANISH)
by: Infantes-Burgos Ronald Javier, et al.
Published: (2014-01-01)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
by: Ulrika Rönningås, et al.
Published: (2019-07-01)

Biochemical recurrence after radical prostatectomy: what does it mean?
by: Rafael Tourinho-Barbosa, et al.

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
by: Ernani L. Rhoden, et al.
Published: (2003-04-01)

Review of Clinical Manifestations of Biochemically-advanced Prostate Cancer Cases
by: Edmund Chiong, et al.
Published: (2005-07-01)

68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
by: Yuigi Yuminaga, et al.
Published: (2021-04-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
by: Tobias Nordström, et al.
Published: (2017-10-01)

Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatectomy?
by: Ricardo Kupka da Silva, et al.
Published: (2013-12-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Jacob H. Cohen, et al.
Published: (2010-02-01)

Are prostate carcinoma clinical stages T1C and T2 similar?
by: Athanase Billis, et al.
Published: (2006-04-01)

Assessment of serum level of prostate-specific antigen adjusted for the transition zone volume in early detection of prostate cancer
by: Marcos D. Ferreira, et al.
Published: (2005-04-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy
by: Marcos F. Dall'Oglio, et al.
Published: (2004-12-01)

A new nomogram to predict pathologic outcome following radical prostatectomy
by: Alexandre Crippa, et al.
Published: (2006-04-01)

Use of the prostate‐specific antigen (PSA) test in the United States for men age ≥65, 1999–2015: Implications for practice interventions
by: Shahram Shahangian, et al.
Published: (2021-08-01)